Copyright Reports & Markets. All rights reserved.

Global In-vitro Diagnostic Services Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
  • 1.4 Market 4
    • 1.4.1 Global In-vitro Diagnostic Services Market Size Growth Rate 4: 2020 VS 2026
    • 1.4.2 Infectious Testing
    • 1.4.3 Diabetes Testing
    • 1.4.4 Molecular Testing
    • 1.4.5 Tissue Testing
  • 1.5 Market by Application
    • 1.5.1 Global In-vitro Diagnostic Services Market Share 4: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Point-Of-Care Testing
    • 1.5.4 Laboratories
    • 1.5.5 Academic Institutes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global In-vitro Diagnostic Services Market Perspective (2015-2026)
  • 2.2 Global In-vitro Diagnostic Services Growth Trends by Regions
    • 2.2.1 In-vitro Diagnostic Services Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 In-vitro Diagnostic Services Historic Market Share by Regions (2015-2020)
    • 2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 In-vitro Diagnostic Services Market Growth Strategy
    • 2.3.6 Primary Interviews with Key In-vitro Diagnostic Services Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top In-vitro Diagnostic Services Players by Market Size
    • 3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2015-2020)
    • 3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global In-vitro Diagnostic Services Market Concentration Ratio
    • 3.2.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2019
  • 3.3 In-vitro Diagnostic Services Key Players Head office and Area Served
  • 3.4 Key Players In-vitro Diagnostic Services Product Solution and Service
  • 3.5 Date of Enter into In-vitro Diagnostic Services Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size 4 (2015-2026)

  • 4.1 Global In-vitro Diagnostic Services Historic Market Size 4 (2015-2020)
  • 4.2 Global In-vitro Diagnostic Services Forecasted Market Size 4 (2021-2026)

5 Market Size 4 (2015-2026)

  • 5.1 Global In-vitro Diagnostic Services Market Size 4 (2015-2020)
  • 5.2 Global In-vitro Diagnostic Services Forecasted Market Size 4 (2021-2026)

6 North America

  • 6.1 North America In-vitro Diagnostic Services Market Size (2015-2020)
  • 6.2 In-vitro Diagnostic Services Key Players in North America (2019-2020)
  • 6.3 North America In-vitro Diagnostic Services Market Size 4 (2015-2020)
  • 6.4 North America In-vitro Diagnostic Services Market Size 4 (2015-2020)

7 Europe

  • 7.1 Europe In-vitro Diagnostic Services Market Size (2015-2020)
  • 7.2 In-vitro Diagnostic Services Key Players in Europe (2019-2020)
  • 7.3 Europe In-vitro Diagnostic Services Market Size 4 (2015-2020)
  • 7.4 Europe In-vitro Diagnostic Services Market Size 4 (2015-2020)

8 China

  • 8.1 China In-vitro Diagnostic Services Market Size (2015-2020)
  • 8.2 In-vitro Diagnostic Services Key Players in China (2019-2020)
  • 8.3 China In-vitro Diagnostic Services Market Size 4 (2015-2020)
  • 8.4 China In-vitro Diagnostic Services Market Size 4 (2015-2020)

9 Japan

  • 9.1 Japan In-vitro Diagnostic Services Market Size (2015-2020)
  • 9.2 In-vitro Diagnostic Services Key Players in Japan (2019-2020)
  • 9.3 Japan In-vitro Diagnostic Services Market Size 4 (2015-2020)
  • 9.4 Japan In-vitro Diagnostic Services Market Size 4 (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia In-vitro Diagnostic Services Market Size (2015-2020)
  • 10.2 In-vitro Diagnostic Services Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia In-vitro Diagnostic Services Market Size by Type (2015-2020)
  • 10.4 Southeast Asia In-vitro Diagnostic Services Market Size by Application (2015-2020)

11 India

  • 11.1 India In-vitro Diagnostic Services Market Size (2015-2020)
  • 11.2 In-vitro Diagnostic Services Key Players in India (2019-2020)
  • 11.3 India In-vitro Diagnostic Services Market Size by Type (2015-2020)
  • 11.4 India In-vitro Diagnostic Services Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America In-vitro Diagnostic Services Market Size (2015-2020)
  • 12.2 In-vitro Diagnostic Services Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America In-vitro Diagnostic Services Market Size by Type (2015-2020)
  • 12.4 Central & South America In-vitro Diagnostic Services Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 BioRad
    • 13.1.1 BioRad Company Details
    • 13.1.2 BioRad Business Overview
    • 13.1.3 BioRad In-vitro Diagnostic Services Introduction
    • 13.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2015-2020))
    • 13.1.5 BioRad Recent Development
  • 13.2 DexCom
    • 13.2.1 DexCom Company Details
    • 13.2.2 DexCom Business Overview
    • 13.2.3 DexCom In-vitro Diagnostic Services Introduction
    • 13.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.2.5 DexCom Recent Development
  • 13.3 Nova Biomedical
    • 13.3.1 Nova Biomedical Company Details
    • 13.3.2 Nova Biomedical Business Overview
    • 13.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
    • 13.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.3.5 Nova Biomedical Recent Development
  • 13.4 OraSure
    • 13.4.1 OraSure Company Details
    • 13.4.2 OraSure Business Overview
    • 13.4.3 OraSure In-vitro Diagnostic Services Introduction
    • 13.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.4.5 OraSure Recent Development
  • 13.5 Pearl Pathways
    • 13.5.1 Pearl Pathways Company Details
    • 13.5.2 Pearl Pathways Business Overview
    • 13.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
    • 13.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.5.5 Pearl Pathways Recent Development
  • 13.6 Phenomenex
    • 13.6.1 Phenomenex Company Details
    • 13.6.2 Phenomenex Business Overview
    • 13.6.3 Phenomenex In-vitro Diagnostic Services Introduction
    • 13.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.6.5 Phenomenex Recent Development
  • 13.7 Qiagen
    • 13.7.1 Qiagen Company Details
    • 13.7.2 Qiagen Business Overview
    • 13.7.3 Qiagen In-vitro Diagnostic Services Introduction
    • 13.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.7.5 Qiagen Recent Development
  • 13.8 Roche Diagnostics
    • 13.8.1 Roche Diagnostics Company Details
    • 13.8.2 Roche Diagnostics Business Overview
    • 13.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
    • 13.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.8.5 Roche Diagnostics Recent Development
  • 13.9 Siemens
    • 13.9.1 Siemens Company Details
    • 13.9.2 Siemens Business Overview
    • 13.9.3 Siemens In-vitro Diagnostic Services Introduction
    • 13.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.9.5 Siemens Recent Development
  • 13.10 Sysmex
    • 13.10.1 Sysmex Company Details
    • 13.10.2 Sysmex Business Overview
    • 13.10.3 Sysmex In-vitro Diagnostic Services Introduction
    • 13.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 13.10.5 Sysmex Recent Development
  • 13.11 Thermofisher
    • 10.11.1 Thermofisher Company Details
    • 10.11.2 Thermofisher Business Overview
    • 10.11.3 Thermofisher In-vitro Diagnostic Services Introduction
    • 10.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2015-2020)
    • 10.11.5 Thermofisher Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    In-vitro Diagnostic Services market is segmented 4, and 4. Players, stakeholders, and other participants in the global In-vitro Diagnostic Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast 4 and 4 in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    BioRad
    DexCom
    Nova Biomedical
    OraSure
    Pearl Pathways
    Phenomenex
    Qiagen
    Roche Diagnostics
    Siemens
    Sysmex
    Thermofisher

    Market segment 4, the product can be split into
    Infectious Testing
    Diabetes Testing
    Molecular Testing
    Tissue Testing
    Market segment 4, split into
    Hospitals
    Point-Of-Care Testing
    Laboratories
    Academic Institutes

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now